Pharmafile Logo

News and Press Releases

Journal of Prevention of Alzheimer’s Disease publishes trial results showing HMTM potentially offers accessible oral treatment option for patients with early Alzheimer’s disease

26 January 2026 -- Scotland, UK -- TauRx Therapeutics Management Ltd today announced results from its Phase III LUCIDITY trial evaluating the efficacy and safety of hydromethylthionine mesylate (HMTM) in...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 26, 2026

TauRx Therapeutics
andy.groundwater@taurx.com
395 King Street Aberdeen AB24 5RP United Kingdom

Plexium Selects Xavo as their Sample Management Lab Operations Platform

24 July 2024 -- Massachusetts, US -- Xavo, a leading provider of innovative software solutions for life sciences R&D, proudly announces Plexium as its latest esteemed client. “We are thrilled...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 24, 2024

Xavo
One Boston Place, Suite 2600 Boston, MA 02108, USA

Touchlight and LenioBio Collaborate to Accelerate Development of Protein Therapeutics for Pandemic Response

Touchlight to participate in LenioBio’s recently announced grant from CEPI 2 July 2024 -- Hampton, UK, and Düsseldorf, Germany -- LenioBio, a biotech company pioneering cell-free protein production, and Touchlight,...

Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: July 2, 2024

Touchlight
info@touchlight.com
Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

ELRIG UK and The Protein Society Partner to Advance Protein Sciences in Drug Discovery

Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK, from 18–19 November 2024 26 June 2024 -- Cambridge, UK and California, US -- The European...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 26, 2024

European Laboratory Research and Innovation Group (ELRIG)
info@elrig.org
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

NEOsphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery

14 May 2024 -- Martinsried, Germany -- NEOsphere Biotechnologies, a German biotechnology company pioneering high-throughput proteomics to systematically build broad and unique portfolios of novel degrader targets at scale, today...

Category: Drug Discovery, Pharmaceutical
Posted: May 14, 2024

NEOsphere Biotechnologies
info@neospherebiotech.com
Fraunhoferstrasse 1 82152 Planegg Germany

X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

28 September 2023 -- Massachusetts, US -- X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership dedicated to accelerating drug discovery through...

Category: Biotechnology
Posted: September 28, 2023

X-Chem
info@x-chemrx.com
100 Beaver Street Waltham, MA 02453